Weekly irinotecan plus UFT and leucovorin as first-line chemotherapy of patients with advanced colorectal cancer.

Méndez, M; Alfonso, P G; Pujol, E; González, E; Castañon, C; Cerezuela, P; López-Mateos, Y; Cruz, J J

Méndez, M; Alfonso, P G; Pujol, E; González, E; Castañon, C; Cerezuela, P; López-Mateos, Y; Cruz, J J.

Affiliation

Méndez M; Hospital de Móstoles, Madrid, Spain.

Invest New Drugs ; 23(3): 243-51, 2005 Jun.

Article in En | MEDLINE | ID: mdl-15868381

Subject(s)

Adenocarcinoma/drug therapy; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Colorectal Neoplasms/drug therapy; Adenocarcinoma/secondary; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Camptothecin/administration & dosage; Camptothecin/analogs & derivatives; Colorectal Neoplasms/pathology; Female; Humans; Irinotecan; Leucovorin/administration & dosage; Male; Middle Aged; Tegafur/administration & dosage; Tegafur/adverse effects; Tegafur/therapeutic use; Uracil/administration & dosage; Uracil/adverse effects; Uracil/therapeutic use

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Invest New Drugs Year: 2005 Type: Article Affiliation country: Spain

Search on Google

XML

PubMed Links